Technical Analysis for KYMR - Kymera Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Stochastic Buy Signal | Bullish | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| NR7 | Range Contraction | 2.82% | |
| Lower Bollinger Band Walk | Weakness | 2.82% | |
| Inside Day | Range Contraction | 2.82% | |
| Lower Bollinger Band Touch | Weakness | 2.82% | |
| Oversold Stochastic | Weakness | 2.82% | |
| MACD Bearish Centerline Cross | Bearish | 3.87% |
| Alert | Time |
|---|---|
| Up 2% | about 19 hours ago |
| Up 1% | about 20 hours ago |
| Rose Above Previous Day's High | about 20 hours ago |
| 60 Minute Opening Range Breakout | about 20 hours ago |
| Lower Bollinger Band Support | about 21 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 10/31/2024
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; and STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases. The company was founded in 2015 and is headquartered in Watertown, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Immunology Solid Tumors Immune System Autoimmune Disease Autoimmunity Rheumatoid Arthritis Hematologic Malignancies Atopic Dermatitis Dermatitis Hidradenitis Suppurativa
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Immunology Solid Tumors Immune System Autoimmune Disease Autoimmunity Rheumatoid Arthritis Hematologic Malignancies Atopic Dermatitis Dermatitis Hidradenitis Suppurativa
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 53.27 |
| 52 Week Low | 18.89 |
| Average Volume | 424,996 |
| 200-Day Moving Average | 40.85 |
| 50-Day Moving Average | 47.00 |
| 20-Day Moving Average | 47.37 |
| 10-Day Moving Average | 46.85 |
| Average True Range | 2.47 |
| RSI (14) | 42.20 |
| ADX | 18.52 |
| +DI | 19.42 |
| -DI | 32.71 |
| Chandelier Exit (Long, 3 ATRs) | 45.81 |
| Chandelier Exit (Short, 3 ATRs) | 48.54 |
| Upper Bollinger Bands | 52.81 |
| Lower Bollinger Band | 41.92 |
| Percent B (%b) | 0.2 |
| BandWidth | 23.00 |
| MACD Line | -0.79 |
| MACD Signal Line | -0.03 |
| MACD Histogram | -0.7649 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 47.06 | ||||
| Resistance 3 (R3) | 46.74 | 45.42 | 46.56 | ||
| Resistance 2 (R2) | 45.42 | 44.66 | 45.58 | 46.39 | |
| Resistance 1 (R1) | 44.74 | 44.18 | 45.08 | 45.05 | 46.22 |
| Pivot Point | 43.42 | 43.42 | 43.59 | 43.58 | 43.42 |
| Support 1 (S1) | 42.73 | 42.65 | 43.08 | 43.05 | 41.88 |
| Support 2 (S2) | 41.41 | 42.18 | 41.57 | 41.71 | |
| Support 3 (S3) | 40.73 | 41.41 | 41.54 | ||
| Support 4 (S4) | 41.04 |
